These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intravenous immunoglobulin in two children with Guillain-Barré syndrome. Notarangelo LD; Duse M; Tiberti S; Guarneri B; Brunori A; Negrini A; Ugazio AG Eur J Pediatr; 1993 Apr; 152(4):372-4. PubMed ID: 8482293 [TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin. Uldry PA; Bogousslavsky J; Regli F Schweiz Arch Neurol Psychiatr (1985); 1991; 142(4):301-5. PubMed ID: 1719624 [TBL] [Abstract][Full Text] [Related]
6. Second response to immunoglobulin in recurrent Guillain-Barré syndrome. Nagappan R; Barker J N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925 [TBL] [Abstract][Full Text] [Related]
7. Immune globulin therapy in children with Guillain-Barré syndrome. Goodhew PM; Johnston HM Muscle Nerve; 1996 Nov; 19(11):1490-2. PubMed ID: 8874410 [No Abstract] [Full Text] [Related]
8. [Use of intravenous immunoglobulins in Guillain-Barré syndrome]. Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group. Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group. Visser LH; van der Meché FG; Meulstee J; van Doorn PA J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):242-4. PubMed ID: 9489539 [TBL] [Abstract][Full Text] [Related]
11. Compatibility problems after intravenous immunoglobulin--a case report. Sulochana PV; Mathai J; Sathyabhama S; Augustine P Indian J Pathol Microbiol; 1998 Oct; 41(4):495-8. PubMed ID: 9866917 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins i.v.: a new approach to the treatment of Guillain-Barré syndrome. Fasanaro AM; Pizza V; Rossi V Minerva Med; 1996; 87(1-2):17-20. PubMed ID: 8610020 [TBL] [Abstract][Full Text] [Related]
14. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. Kleyweg RP; van der Meché FG J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin in the Guillain-Barré syndrome. Products with low IgA content may be used in patients with total IgA deficiency. Misbah S BMJ; 1996 Nov; 313(7069):1400. PubMed ID: 8956720 [No Abstract] [Full Text] [Related]
16. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome. Ng KK; Howard RS; Hirsch NP; Miller DH Neurology; 1993 Dec; 43(12):2729; author reply 2730-1. PubMed ID: 8255495 [No Abstract] [Full Text] [Related]
17. Intravenous IgG in Guillain-Barré syndrome. Hughes RA BMJ; 1996 Aug; 313(7054):376-7. PubMed ID: 8761208 [No Abstract] [Full Text] [Related]
18. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related]
19. [Intravenous immunoglobulins in Guillain-Barré syndrome]. Hidou M; Olivier J; Vivant JF Ann Fr Anesth Reanim; 1992; 11(1):115. PubMed ID: 1443803 [No Abstract] [Full Text] [Related]
20. Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin. Heaton PA N Z Med J; 1992 Nov; 105(946):477-8. PubMed ID: 1436876 [No Abstract] [Full Text] [Related] [Next] [New Search]